Skip to content
Black History Month is a time to reflect and recognize the significant contributions and achievements Black Americans have made—both as participants and leaders—in the clinical research profession.
Thank you for all you do to promote excellence in clinical research.
“We all have a role to play in making clinical trials more diverse and inclusive. It starts with study design, which must be built around the patient, keeping them at the heart of the trial.”
— Otis Johnson, PhD, MPA, Chief Diversity, Inclusion & Sustainability Officer, Clario; ACRP Diversity Advisory Council Member
READ MORE > Diversity in Clinical Trials: Advances and Areas for Improvement
“Black History Month is a time to reflect and acknowledge the industry trailblazers of the past while implementing pathways for greater diversity in clinical research—for clinical trials participants and the site workforce.”
— Danielle Mitchell, CEO and Founder, Black Women in Clinical Research; ACRP Diversity Advisory Council Member
“We must find better ways to promote and grow minorities in the clinical trial workforce. They can make an even greater contribution to this noble and purposeful profession, but we must find the mechanisms to advance people of color.”
— R’Kes Starling, RPh, MBA, Chief Executive Officer/President, Reveles Clinical Services; ACRP Diversity Advisory Council Member
READ MORE > Black History Month Inspires Efforts to Advance Diversity in Clinical Trials
“Black History Month is a time of reflection on past adversities and lessons learned, and celebrations of continual progress and resilience. As an industry professional, I appreciate the work done to address the injustices, and I’m honored to be a part of the path forward to health equity.”
— Ashley Moultrie, Director, DEI & Community Engagement, Javara; ACRP Diversity Advisory Council Member
“I am who I am today due to the unsung Black heroes who blazed trails and were dedicated to a cause greater than themselves. I thank them for paving the way for my success as a clinical researcher and the opportunities my grandchildren have due to their bravery in breaking down barriers.”
— Pamela Nelson, PhD, MSN, Founder and CEO, Bracane Company, Inc.; ACRP Diversity Advisory Council Member
“As a physician and clinical researcher, Black History Month is a time to acknowledge how history has contributed to racial health disparities in research and medicine, and to work toward efforts to rebuild trust and improve representation in all areas of healthcare and research.”
— Tiffany T. Mayo, MD, Associate Professor, Dermatology, University of Alabama at Birmingham
“ACRP has enhanced my professional networks and impacted my career development. I’m proud to be associated with an institution that supports diversity and inclusion amongst all clinical research professionals.”
— Brandi Wallace, Clinical Research Associate, Premier Research
Association of Clinical Research Professionals’ Response to FDA Draft Guidance on Clinical Trials Diversity
The ACRP Diversity Advisory Council was published in Update, the quarterly magazine of the Food and Drug Law Institute. DAC members—who have extensive day-to-day experience on the realities of running clinical trials—provided their viewpoints on the pathways forward for sites and sponsors. Shared with the permission of FDLI.
Meet the ACRP Diversity Advisory Council Members
The Diversity Advisory Council (DAC) is a group of industry leaders who serve as a volunteer resource supporting ACRP’s efforts to increase diversity in the clinical research workforce.
DAC members recommend strategies to recruit and retain outstanding, high-quality clinical research professionals and students from historically underrepresented groups.